SCHEMBL14748423

SCHEMBL14748423

CCN(C)CCN(C)c1ccccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 4/20 0.51
CYP2C19 P33261 2/20 0.51
CHRM2 P08172 3/20 0.44
ADRA2A P08913 3/20 0.44
DRD1 P21728 3/20 0.44
SLC6A2 P23975 3/20 0.44
SLC6A4 P31645 3/20 0.44
SLC6A3 Q01959 3/20 0.44
KCNH2 Q12809 3/20 0.44
ADRA1A P35348 2/20 0.44
ADRA2B P18089 2/20 0.44
HTR2A P28223 2/20 0.44
HRH1 P35367 2/20 0.44
ADRA2C P18825 1/20 0.44
OPRK1 P41145 1/20 0.44
KDM4E B2RXH2 5/20 0.43
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CHRNB2 P17787 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16491477 0.84 CHRM2 (0.54) CYP2D6CYP2C19CHRM2ADRA2ADRD1
SCHEMBL434743 0.83 CYP2D6 (0.56) CYP2D6CYP2C19CHRM2ADRA2ADRD1
SCHEMBL4445537 0.83 CYP2D6 (0.72) CYP2D6CYP2C19CHRM2ADRA2ADRD1
SCHEMBL2760196 0.83 CYP2D6 (0.55) CYP2D6CYP2C19CHRM2ADRA2ADRD1
Hydrochloric Acid SCHEMBL5379223 0.81 CYP2D6 (0.55) CYP2D6CYP2C19CHRM2ADRA2ADRD1
SCHEMBL1276585 0.81 CHRM2 (0.59) CYP2D6CYP2C19CHRM2ADRA2ADRD1
Hydrochloric Acid SCHEMBL28388436 0.81 CYP2D6 (0.53) CYP2D6CYP2C19CHRM2ADRA2ADRD1
SCHEMBL6439932 0.80 CYP2D6 (0.53) CYP2D6CYP2C19CHRM2ADRA2ADRD1
SCHEMBL12120297 0.79 CYP2D6 (0.45) CYP2D6CYP2C19CHRM2ADRA2ADRD1
Alcohol SCHEMBL7553089 0.79 POLB (0.54) CYP2D6CYP2C19CHRM2ADRA2ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2316831-B1 2-(morpholin-4-yl)pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer NOVARTIS AG (CH) 2013-03-06 EP disclosed